Cargando…
Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071067/ https://www.ncbi.nlm.nih.gov/pubmed/32181442 http://dx.doi.org/10.1089/caff.2019.0020 |
_version_ | 1783506117586845696 |
---|---|
author | Sweeney, Mary M. Weaver, Darian C. Vincent, Kathryn B. Arria, Amelia M. Griffiths, Roland R. |
author_facet | Sweeney, Mary M. Weaver, Darian C. Vincent, Kathryn B. Arria, Amelia M. Griffiths, Roland R. |
author_sort | Sweeney, Mary M. |
collection | PubMed |
description | Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demographic quotas to reflect the U.S. population. Caffeine consumption, DSM-proposed criteria for caffeine use disorder, sleep, substance use, and psychological distress were assessed. Results: Eight percent of the sample fulfilled DSM-proposed criteria for caffeine use disorder. These individuals consumed more caffeine, were younger, and were more likely to be cigarette smokers. Fulfilling caffeine use disorder criteria was associated with caffeine-related functional impairment, poorer sleep, some substance use, as well as greater depression, anxiety, and stress. Conclusions: The prevalence of caffeine use disorder among the present sample suggests that the proposed diagnostic criteria would identify only a modest percentage of the general population, and that identified individuals experience significant caffeine-related distress. |
format | Online Article Text |
id | pubmed-7071067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-70710672020-03-16 Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample Sweeney, Mary M. Weaver, Darian C. Vincent, Kathryn B. Arria, Amelia M. Griffiths, Roland R. J Caffeine Adenosine Res Original Articles Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demographic quotas to reflect the U.S. population. Caffeine consumption, DSM-proposed criteria for caffeine use disorder, sleep, substance use, and psychological distress were assessed. Results: Eight percent of the sample fulfilled DSM-proposed criteria for caffeine use disorder. These individuals consumed more caffeine, were younger, and were more likely to be cigarette smokers. Fulfilling caffeine use disorder criteria was associated with caffeine-related functional impairment, poorer sleep, some substance use, as well as greater depression, anxiety, and stress. Conclusions: The prevalence of caffeine use disorder among the present sample suggests that the proposed diagnostic criteria would identify only a modest percentage of the general population, and that identified individuals experience significant caffeine-related distress. Mary Ann Liebert, Inc., publishers 2020-03-01 2020-03-04 /pmc/articles/PMC7071067/ /pubmed/32181442 http://dx.doi.org/10.1089/caff.2019.0020 Text en © Mary M. Sweeney, et al. 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Sweeney, Mary M. Weaver, Darian C. Vincent, Kathryn B. Arria, Amelia M. Griffiths, Roland R. Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title | Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title_full | Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title_fullStr | Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title_full_unstemmed | Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title_short | Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample |
title_sort | prevalence and correlates of caffeine use disorder symptoms among a united states sample |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071067/ https://www.ncbi.nlm.nih.gov/pubmed/32181442 http://dx.doi.org/10.1089/caff.2019.0020 |
work_keys_str_mv | AT sweeneymarym prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample AT weaverdarianc prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample AT vincentkathrynb prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample AT arriaameliam prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample AT griffithsrolandr prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample |